Quantcast
Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

Most Watched Stocks List: 100 Dividend Stocks That Should Be on Your Radar

Dividend logo
  • STOCK
  • AMGN
  • PRICE AS OF: Feb 24, 05:45 PM EST
  • $174.56 +$0.55 +0.3%
  • INDUSTRY
  • Biotechnology

AMGN
Stock Dividend Data

DIVIDEND YIELD ?

2.64%
Healthcare Average 0.92%

ANUALIZED PAYOUT ?

$4.60
Paid Quarterly

PAYOUT RATIO ?

37.5%
EPS $12.27

DIVIDEND GROWTH ?

6 yrs
Since 2011

AMGN
Daily Snapshot

PRICE

$174.56

QUOTE TIME

Feb 24, 05:45 PM

TODAY'S VOLUME

2,677,300

OPEN PRICE

$173.29

DAY'S RANGE

$172.48 - $174.72

PREVIOUS CLOSE

$174.01

52 WEEK LOW / HIGH

$133.64 - $176.85

PERCENT OFF 52 WEEK HIGH

-1.29%

AMGN
Upcoming Dividend Payouts

AMGN has not yet officially announced its next dividend payout.

Capture Amgen Dividend with Much Less Risk

Analyze over 20+ ETFs with Significant Exposure to AMGN

AMGN
Dividend.com DARS Rating™ Breakdown for AMGN

Sign Up
Metric AMGN Rank AMGN Avg Ranking Notes
Relative Strength 1 year return is slightly above Benchmark/Peers/Broader Market/Analyst Expectations
Overall Yield Attractiveness Yield is at par with Benchmark/Peers/Broader Market/Analyst Expectations
Dividend Reliability Payout ratio is considerably higher than industry average and peers
Dividend Uptrend Dividends are above average, growing as per Benchmark/Peers/Broader Market/Analyst Expectations
Earnings Growth EPS growth is at par with Benchmark/Peers/Broader Market/Analyst Expectations
DARS Rating

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks

AMGN
Dividend Growth History

Annualized Growth
1994-2012
Annualized Growth
1994-2004
Annualized Growth
2004-2008
Annualized Growth
2008-2012
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Annual
Growth
2016
Consecutive
Years of
Increases
28.6% 26.6% 6 years
Unlock Dividend Growth History

AMGN
Research

AMGN
Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
2016
2015
Unlock Historical Annual Dividend Data & Growth

Brought to You by Mitre Media

AMGN
Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$1.1500 2016-12-20 2017-02-13 2017-02-15 2017-03-08 Yes Regular Quarter
$1.0000 2016-10-14 2016-11-14 2016-11-16 2016-12-08 Yes Regular Quarter
$1.0000 2016-07-22 2016-08-15 2016-08-17 2016-09-08 Yes Regular Quarter
$1.0000 2016-03-02 2016-05-13 2016-05-17 2016-06-08 Yes Regular Quarter
$1.0000 2015-12-15 2016-02-11 2016-02-16 2016-03-08 Yes Regular Quarter
$0.7900 2015-10-14 2015-11-12 2015-11-16 2015-12-07 Yes Regular Quarter
$0.7900 2015-07-28 2015-08-13 2015-08-17 2015-09-08 Yes Regular Quarter
$0.7900 2015-03-04 2015-05-12 2015-05-14 2015-06-05 Yes Regular Quarter
$0.7900 2014-12-17 2015-02-10 2015-02-12 2015-03-06 Yes Regular Quarter
$0.6100 2014-10-17 2014-11-10 2014-11-13 2014-12-05 Yes Regular Quarter
$0.6100 2014-07-25 2014-08-12 2014-08-14 2014-09-05 Yes Regular Quarter
$0.6100 2014-03-05 2014-05-13 2014-05-15 2014-06-06 Yes Regular Quarter
$0.6100 2013-12-13 2014-02-11 2014-02-13 2014-03-07 Yes Regular Quarter
$0.4700 2013-10-16 2013-11-12 2013-11-14 2013-12-06 Yes Regular Quarter
$0.4700 2013-07-26 2013-08-14 2013-08-16 2013-09-06 Yes Regular Quarter
$0.4700 2013-03-06 2013-05-14 2013-05-16 2013-06-07 Yes Regular Quarter
$0.4700 2012-12-13 2013-02-11 2013-02-13 2013-03-07 Yes Regular Quarter
$0.3600 2012-10-11 2012-11-13 2012-11-15 2012-12-07 Yes Regular Quarter
$0.3600 2012-07-19 2012-08-14 2012-08-16 2012-09-07 Yes Regular Quarter
$0.3600 2012-03-15 2012-05-14 2012-05-16 2012-06-07 Yes Regular Quarter
$0.3600 2011-12-15 2012-02-13 2012-02-15 2012-03-07 Yes Regular Quarter
$0.2800 2011-10-13 2011-11-15 2011-11-17 2011-12-08 Yes Regular Quarter
$0.2800 2011-07-28 2011-08-16 2011-08-18 2011-09-08 Yes Regular Quarter
2-for-1 1999-10-20 1999-11-22 1999-11-05 1999-11-19 NM Stock Split NM
2-for-1 1999-01-28 1999-03-01 1999-02-12 1999-02-26 NM Stock Split NM
$0.0002 1997-02-19 1997-03-24 1997-03-21 1997-03-21 Unknown Unknown unknown
2-for-1 1995-07-20 1995-08-16 1995-08-01 1995-08-15 NM Stock Split NM

AMGN
Investor Resources

Learn more about Amgen on:

Company Website For more information, visit the company website.
Investor Relations Here you can find contact information on how to get in touch with the company.
Wiki Page Visit the company page on Wikipedia.
SEC Filings Get access to filings such as 8-K, 10-K, 13-D, Proxy Statements and more.

AMGN
Company Profile

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology

Amgen (AMGN) - this company discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body's response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Knowledge Centers